Page last updated: 2024-10-29

ioxilan and Adrenocortical Carcinoma

ioxilan has been researched along with Adrenocortical Carcinoma in 1 studies

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research Excerpts

ExcerptRelevanceReference
"Adrenocortical carcinoma has relative contrast retention on delayed contrast-enhanced CT."1.33Adrenocortical carcinoma: contrast washout characteristics on CT. ( Blake, MA; Boland, GW; Copeland, PM; Kalra, MK; Misdraji, J; Mueller, PR; Slattery, JM; Sweeney, AT, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Slattery, JM1
Blake, MA1
Kalra, MK1
Misdraji, J1
Sweeney, AT1
Copeland, PM1
Mueller, PR1
Boland, GW1

Other Studies

1 other study available for ioxilan and Adrenocortical Carcinoma

ArticleYear
Adrenocortical carcinoma: contrast washout characteristics on CT.
    AJR. American journal of roentgenology, 2006, Volume: 187, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Contrast Media;

2006